Jane Street
AIMT

Jane Street’s Aimmune Therapeutics AIMT Stock Holding History

Jane Street’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-7,100
Closed -$245K – 8520
2020
Q3 		$245K Sell
7,100
-11,000
-61% -$234K ﹤0.01% 6167
2020
Q2 		$302K Buy
+18,100
New +$307K ﹤0.01% 5823

Jane Street's AIMT Position: Q4 2020 in Review

Jane Street sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 90,855 shares — an estimated $3.13M sold.

Jane Street first reported a position in AIMT in Q3 2015 and held it in 7 quarters. The position peaked at $3.13M in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

  • Jane Street reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
  • Jane Street sold 90,855 Aimmune Therapeutics shares in Q4 2020, an estimated $3.13M.
  • Jane Street first reported a position in Aimmune Therapeutics in Q3 2015 and held it in 7 quarters.
  • Jane Street's Aimmune Therapeutics position peaked at $3.13M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Jane Street's 13F filing for Q4 2020, filed 17 Feb 2021.